What is the diagnostic approach for Myalgic Encephalomyelitis (ME)?

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is diagnosed clinically using the 2015 National Academy of Medicine (Institute of Medicine) criteria, which require three core symptoms: substantial reduction in activity lasting >6 months, post-exertional malaise (PEM), and unrefreshing sleep, plus either cognitive impairment or orthostatic intolerance. 1, 2

Diagnostic Criteria Algorithm

The diagnosis requires all three mandatory features:

1. Substantial reduction or impairment in activity levels that persists for more than 6 months and is accompanied by profound fatigue
2. Post-exertional malaise (PEM) - worsening of symptoms following physical, cognitive, or emotional exertion, often delayed by 12-48 hours
3. Unrefreshing sleep - patients wake feeling as exhausted as when they went to bed

Plus at least one of the following two manifestations:

• Cognitive impairment - problems with thinking, memory, information processing ("brain fog")
• Orthostatic intolerance - worsening symptoms upon standing, improved by lying down

2, 1

Critical Diagnostic Considerations

What Makes ME/CFS Different from Other Fatigue Conditions

The hallmark distinguishing feature is post-exertional malaise (PEM) - this is not simple tiredness after activity but a pathological worsening of all symptoms that can last days to weeks after minimal exertion. This separates ME/CFS from depression, deconditioning, or other fatigue states 2.

Exclusionary Process

You must rule out alternative explanations through targeted testing based on clinical presentation. There is no single diagnostic test for ME/CFS 1, 2. Essential exclusions include:

• Sleep disorders (sleep apnea, narcolepsy) - polysomnography if suspected
• Endocrine disorders (hypothyroidism, adrenal insufficiency, diabetes) - TSH, cortisol, glucose
• Rheumatologic conditions (lupus, rheumatoid arthritis, Sjögren's) - ANA, RF, inflammatory markers
• Infectious diseases (chronic hepatitis, HIV, Lyme disease) - targeted serology
• Cardiac/pulmonary disease - as clinically indicated
• Malignancy - age-appropriate screening
• Primary psychiatric disorders - though depression/anxiety can coexist with ME/CFS

2

Objective Documentation (Research/Disability Settings)

While not required for clinical diagnosis, 2-day cardiopulmonary exercise testing (CPET) can objectively document the abnormal physiological response to exertion characteristic of ME/CFS. Patients show reduced oxygen consumption (VO2 max) on day 2 compared to day 1, which does not occur in healthy individuals or those with deconditioning 3, 2.

Severity Spectrum Recognition

ME/CFS exists on a severity spectrum 4:

• Mild: Can perform self-care but may need to stop working
• Moderate: Reduced mobility, restricted to house most days
• Severe: Mostly bedbound, unable to perform basic self-care
• Very severe: Bedbound 24/7, unable to tolerate light, sound, or touch 3

Patients meeting stricter "ME" criteria (emphasizing neuroinflammatory symptoms) represent a more severely affected subset of the broader ME/CFS population 1, 4.

Common Diagnostic Pitfalls

Up to 91% of ME/CFS patients in the United States remain undiagnosed 2. Major errors include:

• Attributing symptoms solely to depression/anxiety - while these can coexist, they don't explain PEM or the characteristic symptom pattern
• Recommending graded exercise therapy - this has been withdrawn as inappropriate treatment and can cause severe harm by triggering PEM 2
• Waiting for a positive laboratory test - no routine lab test exists; diagnosis is clinical 1
• Dismissing patients as "deconditioned" - deconditioning improves with exercise; ME/CFS worsens 2

Post-COVID-19 Context

A significant percentage of patients with post-acute COVID-19 syndrome meet ME/CFS criteria 2. The same diagnostic approach applies, though the 6-month duration requirement may be considered in context of the acute COVID-19 illness onset.

Practical Clinical Approach

When evaluating suspected ME/CFS:

1. Document the three core symptoms with specific examples from the patient's life (e.g., "Previously worked full-time, now bedbound 3 days after grocery shopping")
2. Confirm PEM pattern - ask about delayed symptom worsening after specific activities
3. Perform targeted exclusionary testing based on clinical red flags, not shotgun testing
4. Avoid over-investigation - extensive negative workup in appropriate clinical context supports the diagnosis
5. Make the diagnosis - don't leave patients in diagnostic limbo waiting for a test that doesn't exist

2, 5

The evidence base for diagnostic methods remains limited by heterogeneous study populations and lack of validation in clinically uncertain cases 1, but the 2015 NAM criteria represent the current evidence-based standard adopted by the CDC 2.